Extracellular vesicles as a next-generation drug delivery platform

2021/07/01 by Inge K. Herrmann, Inge Katrin Herrmann, Matthew J. A. Wood +2 · 14 citations
Biochemistry, Genetics and Molecular Biology · Engineering · #Extracellular vesicles in disease #MicroRNA in disease regulation #Nanoplatforms for cancer theranostics

paper · pdf · doi:10.1038/s41565-021-00931-2

crossref issued 2021/07/01 · crossref published 2021/07/01 · crossref published-online 2021/07/01 · crossref published-print 2021/07/01 · openalex publication_date 2021/07/01 · crossref created 2021/07/01 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Drug delivery systems for RNA therapeutics
• Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles
• Biomimetically engineered plant-derived exosomes-like nanovesicles for rheumatoid arthritis therapy
• Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
• Red blood cell-derived extracellular vesicles as biomaterials: the opportunity of freezing-induced accelerated aging
• Cytosolic protein delivery <i>via</i> protein-bound microparticles based on anionic boron clusters and cationic polymers
• Extracellular vesicles and the lung: from disease pathogenesis to biomarkers and treatments
• Adhesion-driven vesicle translocation through membrane-covered pores
• The blood–brain barrier: Structure, regulation and drug delivery
• Extracellular vesicle cargo from lipofibroblasts mitigates chronic obstructive pulmonary disease by alveolar type 2 cell restoration
• Membrane Heterogeneity Driven Dynamics of Multicomponent Vesicles in Shear Flow
• Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
• Extracellular vesicle-based targeted protein degradation platform for multiple extracellular proteins
• Engineering Yeast Extracellular Vesicle Biogenesis Through Rewiring Membrane Trafficking Pathways